- Job Cuts Fall to Lowest in Nearly 2 Years: Challenger
- Wal-Mart Targets Video Games with Latest Price Cuts
- 'Black Swan' Shuns Public Life Because of Bernanke
- Look Ahead: Markets Count Down to US Jobs Report
- Dubai World To Meet with Creditors Next Week
- FHA to Toughen Mortgage Rules in Lenders Crackdown
- Obama to Send More Troops; Seeks Afghanistan Exit
- GM Removes CEO Henderson; Whitacre Is Interim Chief
- UK Economy Turned, Inflation to Spike: BoE Economist
- Unemployment to Peak at 10.5%: Moody's Economist
- 8 Stocks to Gain on Obama's Afghan Plan: Analysts
- BofA On Proposed Changes In The Housing Bailout Program
- The Future of The Media Landscape
- November Auto Sales Muddle Along
- Busch: What Obama Won't Say Tonight
- Stick with Equities—Avoid Emerging Markets: Laszlo Birinyi
- Pfizer Chomps On A Carrot
- Predictions 2010: Technology
MOST SHARED
- Keeping America Great
- Cisco Has 84% of Tandberg, Won't Extend Bid
- Kohlberg Kravis Bidding for Morgan Stanley's CICC Stake
- Case Closed but Woods Scrutiny Continues
- Australia Regulator Opposes Caltex-Exxon Deal
- UK Economy Turned, Inflation to Spike: BoE Economist
- Toyota Takes Lead Position in Canada in November
- Hyundai's US Auto Sales Jump 46% in November
Text Size 
Digital camera and medical equipment maker Fujifilm Holdings said on Wednesday it will spend up to 155 billion yen ($1.45 billion) to take control of drug maker Toyama Chemical to grow in the pharmaceuticals market.
Fujifilm, the world's second-largest maker of endoscopes behind Olympus, is offering 880 yen per Toyama Chemical share in a tender offer from Feb 19 to March 18 -- a 39 percent premium to its latest close.
Fujifilm will aim to buy at least 73.19 million shares, but will purchase all shares tendered with the exception of the 43 million shares, or 22 percent stake, held by top Toyama shareholder Taisho Pharmaceutical.
That means Fujifilm's total bill for the tender offer could reach 135 billion yen.
In addition, Fujifilm will buy about 20 billion yen worth of new shares issued by Toyama Chemical in a private placement at the end of February. Taisho Pharmaceutical will also buy about 10 billion yen worth of newly issued shares.
Fujifilm said in a statement that its stake in Toyama could total about 76 percent following the tender offer and private placement, but that it ultimately aims to hold a stake of about 66 percent and for Taisho to hold about 34 percent.
Robust sales of endoscopes, used to examine internal organs, have driven growth at Fujifilm. The precision equipment maker hopes the acquisition of Toyama Chemical, best known for a bird flu drug candidate, will help it expand into preventive care and treatment.
News of the bid was first reported in the morning edition of the Nikkei business daily.
Shares of Fujifilm fell 1.5 percent to close at 3,890 yen, while Taisho dropped 1.6 percent to 2,195 yen. Toyama's stock was untraded throughout the day due to a glut of buy orders and closed at 731 yen, up 15.8 percent.
Print
Email
- Will the Fed raise rates? Will the dollar continue its slide? CNBC experts weigh in on the year ahead.
- CNBC’s Larry Kudlow offers Tiger Woods some advice on dealing with tabloid scrutiny.
- Goldman Sachs has forbidden employees from gathering in private holiday parties of 12 or more.
- Dictionary.com says that of all words searched for in 2009, a synonym for greed was the top gainer.
- Heavily armed pirates in Somalia have set up a sort of stock exhange to fund their hijackings.
- Since its launch in 1998, Google has become a primary force on the Internet. How much do you know about the company?
Data is a real-time snapshot *Data is delayed at least 15 minutes